Sanofi US

210 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.

Start with

and connect to

Browse all held record sources

Sanofi US: all 144 bills it lobbied on and all 66 lawmakers it gave to or whose bills it lobbied on. Point at anyone to see how they are linked.Includes 1 other record under the same name, such as its political action committee and state lobbying filings.

Every link on this map

The same connections as a table, with the reason each one is here.

Sort by

Connections of Sanofi US

AB 501	Bills it lobbied on	Sanofi US named AB 501, “Pharmaceutical devices”, in 6 lobbying reports.	6 reports
AB 1280	Bills it lobbied on	Sanofi US named AB 1280, “Ephedrine: retail sale”, in 5 lobbying reports.	5 reports
SB 419	Bills it lobbied on	Sanofi US named SB 419, “Solid waste: home-generated sharps”, in 5 lobbying reports.	5 reports
SB 212	Bills it lobbied on	Sanofi US named SB 212, “Solid waste: pharmaceutical and sharps waste stewardship”, in 4 lobbying reports.	4 reports
AB 542	Bills it lobbied on	Sanofi US named AB 542, “Hospital acquired conditions”, in 4 lobbying reports.	4 reports
SB 17	Bills it lobbied on	Sanofi US named SB 17, “Health care: prescription drug costs”, in 4 lobbying reports.	4 reports
SB 486	Bills it lobbied on	Sanofi US named SB 486, “Medical waste: sharps waste”, in 4 lobbying reports.	4 reports
SB 598	Bills it lobbied on	Sanofi US named SB 598, “Biosimilars”, in 3 lobbying reports.	3 reports
AB 1460	Bills it lobbied on	Sanofi US named AB 1460, “Prescription drug pricing”, in 3 lobbying reports.	3 reports
AB 874	Bills it lobbied on	Sanofi US named AB 874, “Health care coverage: out-of-pocket expenses”, in 3 lobbying reports.	3 reports
SB 1266	Bills it lobbied on	Sanofi US named SB 1266, “Pupil health: epinephrine auto-injectors”, in 3 lobbying reports.	3 reports
SB 738	Bills it lobbied on	Sanofi US named SB 738, “Pupil health: epinephrine auto-injectors: liability limitation”, in 3 lobbying reports.	3 reports
AB 2139	Bills it lobbied on	Sanofi US named AB 2139, “Solid waste: product stewardship”, in 3 lobbying reports.	3 reports
AB 265	Bills it lobbied on	Sanofi US named AB 265, “Prescription drugs: prohibition on price discount”, in 3 lobbying reports.	3 reports
AB 2069	Bills it lobbied on	Sanofi US named AB 2069, “Immunizations: influenza”, in 3 lobbying reports.	3 reports
AB 45	Bills it lobbied on	Sanofi US named AB 45, “Household hazardous waste”, in 3 lobbying reports.	3 reports
AB 347	Bills it lobbied on	Sanofi US named AB 347, “Health care coverage: step therapy”, in 3 lobbying reports.	3 reports
AB 2112	Bills it lobbied on	Sanofi US named AB 2112, “Prescription Record Privacy Act”, in 3 lobbying reports.	3 reports
AB 830	Bills it lobbied on	Sanofi US named AB 830, “Drugs and devices”, in 3 lobbying reports.	3 reports
AB 1880	Bills it lobbied on	Sanofi US named AB 1880, “Prior authorization and step therapy”, in 3 lobbying reports.	3 reports
SB 1010	Bills it lobbied on	Sanofi US named SB 1010, “Health care: prescription drug costs”, in 3 lobbying reports.	3 reports
SB 207	Bills it lobbied on	Sanofi US named SB 207, “Elections: voter registration: partisan primary elections”, in 3 lobbying reports.	3 reports
AB 2203	Bills it lobbied on	Sanofi US named AB 2203, “Insulin cost-sharing cap”, in 3 lobbying reports.	3 reports
SB 790	Bills it lobbied on	Sanofi US named SB 790, “Dreissenid mussel infestation prevention: grants”, in 3 lobbying reports.	3 reports
SB 496	Bills it lobbied on	Sanofi US named SB 496, “Biomarker testing”, in 3 lobbying reports.	3 reports
SB 1014	Bills it lobbied on	Sanofi US named SB 1014, “Pharmaceutical waste: home generated: collection”, in 3 lobbying reports.	3 reports
SB 912	Bills it lobbied on	Sanofi US named SB 912, “Biomarker testing”, in 3 lobbying reports.	3 reports
AB 1394	Bills it lobbied on	Sanofi US named AB 1394, “Prescription drugs”, in 2 lobbying reports.	2 reports
AB 1130	Bills it lobbied on	Sanofi US named AB 1130, “California Health Care Quality and Affordability Act”, in 2 lobbying reports.	2 reports
SB 1104	Bills it lobbied on	Sanofi US named SB 1104, “Health care coverage: diabetes-related complications”, in 2 lobbying reports.	2 reports
SB 966	Bills it lobbied on	Sanofi US named SB 966, “Pharmacy benefits”, in 2 lobbying reports.	2 reports
AB 1069	Bills it lobbied on	Sanofi US named AB 1069, “Prescription drugs: collection and distribution program”, in 2 lobbying reports.	2 reports
AB 689	Bills it lobbied on	Sanofi US named AB 689, “Health facilities: influenza”, in 2 lobbying reports.	2 reports
SB 1052	Bills it lobbied on	Sanofi US named SB 1052, “Health care coverage”, in 2 lobbying reports.	2 reports
AB 1917	Bills it lobbied on	Sanofi US named AB 1917, “Outpatient prescription drugs: cost sharing”, in 2 lobbying reports.	2 reports
AB 333	Bills it lobbied on	Sanofi US named AB 333, “Medical waste”, in 2 lobbying reports.	2 reports
AB 1592	Bills it lobbied on	Sanofi US named AB 1592, “California Diabetes Program”, in 2 lobbying reports.	2 reports
AB 2180	Bills it lobbied on	Sanofi US named AB 2180, “Health care coverage: cost sharing”, in 2 lobbying reports.	2 reports
SB 1307	Bills it lobbied on	Sanofi US named SB 1307, “Pharmacy: pedigree”, in 2 lobbying reports.	2 reports
SB 671	Bills it lobbied on	Sanofi US named SB 671, “Pharmacy: biological product”, in 2 lobbying reports.	2 reports
SB 727	Bills it lobbied on	Sanofi US named SB 727, “Medical waste: pharmaceutical product stewardship program”, in 2 lobbying reports.	2 reports
SB 506	Bills it lobbied on	Sanofi US named SB 506, “Railroad Tank Car Hazardous Materials Safety Fund”, in 2 lobbying reports.	2 reports
AB 2761	Bills it lobbied on	Sanofi US named AB 2761, “Product safety: plastic packaging: Reducing Toxics in Packaging Act”, in 2 lobbying reports.	2 reports
AB 572	Bills it lobbied on	Sanofi US named AB 572, “Diabetes prevention: treatment”, in 2 lobbying reports.	2 reports
AB 369	Bills it lobbied on	Sanofi US named AB 369, “Health care coverage: prescription drugs”, in 2 lobbying reports.	2 reports
AB 2430	Bills it lobbied on	Sanofi US named AB 2430, “Voluntary contributions: Type 1 Diabetes Research Fund”, in 2 lobbying reports.	2 reports
SB 26	Bills it lobbied on	Sanofi US named SB 26, “Hazardous waste: household hazardous waste collection facility: small quantity generators”, in 2 lobbying reports.	2 reports
SB 873	Bills it lobbied on	Sanofi US named SB 873, “Prescription drugs: cost sharing”, in 2 lobbying reports.	2 reports
AB 1000	Bills it lobbied on	Sanofi US named AB 1000, “Health care coverage: cancer treatment”, in 2 lobbying reports.	2 reports
AB 1468	Bills it lobbied on	Sanofi US named AB 1468, “Opioid Prevention and Rehabilitation Act”, in 2 lobbying reports.	2 reports

Showing 50 of 210

In the news

Reporting about the selected subject. Articles are context and do not establish a connection on this map.

Loading coverage…